Quotient Ltd. (QTNT)
NASDAQ:QTNT

Quotient Stock Analysis & Ratings

QTNT Stock Chart & Stats

Day’s Range$0.36 - $0.385
52-Week Range$0.35 - $4.53
Previous Close$0.37
Volume333.48K
Average Volume (3M)613.39K
Market Cap$38.91M
P/E Ratio-0.3
Beta2.69
Next EarningsMay 31, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score7
EPS (TTM)-1.37


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

QTNT FAQ

What was Quotient’s price range in the past 12 months?
Quotient lowest stock price was $0.35 and its highest was $4.53 in the past 12 months.
    What is Quotient’s market cap?
    Quotient’s market cap is $38.91M.
      What is Quotient’s price target?
      The average price target for Quotient is $5.25. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $9.00 ,the lowest forecast is $1.50. The average price target represents 1284.31% Increase from the current price of $0.379.
        What do analysts say about Quotient?
        Quotient’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
          When is Quotient’s upcoming earnings report date?
          Quotient’s upcoming earnings report date is May 31, 2022 which is in 12 days.
            How were Quotient’s earnings last quarter?
            Quotient released its earnings results on Feb 08, 2022. The company reported -$0.44 earnings per share for the quarter, missing the consensus estimate of -$0.258 by -$0.182.
              Is Quotient overvalued?
              According to Wall Street analysts Quotient’s price is currently Undervalued.
                Does Quotient pay dividends?
                Quotient does not currently pay dividends.
                What is Quotient’s EPS estimate?
                Quotient’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Quotient have?
                Quotient has 102,600,000 shares outstanding.
                  What happened to Quotient’s price movement after its last earnings report?
                  Quotient reported an EPS of -$0.44 in its last earnings report, missing expectations of -$0.258. Following the earnings report the stock price went down -3.289%.
                    Which hedge fund is a major shareholder of Quotient?
                    Among the largest hedge funds holding Quotient’s share is Perceptive Advisors LLC. It holds Quotient’s shares valued at 19M.

                      ---

                      Quotient Stock Analysis

                      The Quotient stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Quotient Ltd.

                      Quotient Ltd. is a commercial-stage diagnostics company. It provides immunohematology products to hospitals and blood banks. The company develops, manufactures and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. Quotient was founded on January 28, 2012 and is headquartered in Eysins, Switzerland.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Bio-Rad Laboratories
                      Carlyle Group
                      Haemonetics
                      Cerus
                      International Stem Cell

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis